Related references
Note: Only part of the references are listed.The Effect of Preservative and Temperature on the Analysis of Circulating Tumor DNA
Sonya Parpart-Li et al.
CLINICAL CANCER RESEARCH (2017)
Current and Emerging Applications of Droplet Digital PCR in Oncology
Susana Olmedillas-Lopez et al.
MOLECULAR DIAGNOSIS & THERAPY (2017)
Characteristics, management, and outcomes of patients with hepatocellular carcinoma in Africa: a multicountry observational study from the Africa Liver Cancer Consortium
Ju Dong Yang et al.
LANCET GASTROENTEROLOGY & HEPATOLOGY (2017)
A prominent role of Hepatitis D Virus in liver cancers documented in Central Africa
Marie Atsama Amougou et al.
BMC INFECTIOUS DISEASES (2016)
Comparison of three different DNA extraction methods from a highly degraded biological material
M. Kus et al.
JOURNAL OF FORENSIC AND LEGAL MEDICINE (2016)
Detection of a Tumor Suppressor Gene Variant Predisposing to Colorectal Cancer in an 18th Century Hungarian Mummy
Michal Feldman et al.
PLOS ONE (2016)
Molecular characteristics of Hepatitis B and chronic liver disease in a cohort of HB carriers from Bamako, Mali
Fatou Traore et al.
BMC INFECTIOUS DISEASES (2015)
Exome sequencing of hepatocellular carcinomas identifies new mutational signatures and potential therapeutic targets
Kornelius Schulze et al.
NATURE GENETICS (2015)
Mutation spectrum of hepatocellular carcinoma from eastern-European patients betrays the impact of a complex exposome
Anna-Maria Tanase et al.
JOURNAL OF EXPOSURE SCIENCE AND ENVIRONMENTAL EPIDEMIOLOGY (2015)
Percutaneous microwave ablation vs radiofrequency ablation in the treatment of hepatocellular carcinoma
Loukia S. Poulou et al.
WORLD JOURNAL OF HEPATOLOGY (2015)
Clinical validation of the detection of KRAS and BRAF mutations from circulating tumor DNA
Alain R. Thierry et al.
NATURE MEDICINE (2014)
A Peculiar Mutation Spectrum Emerging from Young Peruvian Patients with Hepatocellular Carcinoma
Agnes Marchio et al.
PLOS ONE (2014)
Detection of Circulating Tumor DNA in Early- and Late-Stage Human Malignancies
Chetan Bettegowda et al.
SCIENCE TRANSLATIONAL MEDICINE (2014)
Problem of hepatocellular carcinoma in West Africa
Nimzing G. Ladep et al.
WORLD JOURNAL OF HEPATOLOGY (2014)
Multimycotoxin analysis in urines to assess infant exposure: A case study in Cameroon
Emmanuel Njumbe Ediage et al.
ENVIRONMENT INTERNATIONAL (2013)
Bio-monitoring of mycotoxin exposure in Cameroon using a urinary multi-biomarker approach
Wilfred A. Abia et al.
FOOD AND CHEMICAL TOXICOLOGY (2013)
The risk of perinatal hepatitis B virus transmission: hepatitis B e antigen (HBeAg) prevalence estimates for all world regions
Joerdis J. Ott et al.
BMC INFECTIOUS DISEASES (2012)
Methods for isolation of cell-free plasma DNA strongly affect DNA yield
Michael Fleischhacker et al.
CLINICA CHIMICA ACTA (2011)
Relationship between codon 249 mutation in exon 7 of p53 gene and diagnosis of hepatocellular carcinoma
Hesham Gamal El-Din et al.
ARCHIVES OF MEDICAL SCIENCE (2010)
Health economic impacts and cost-effectiveness of aflatoxin-reduction strategies in Africa: case studies in biocontrol and post-harvest interventions
F. Wu et al.
FOOD ADDITIVES AND CONTAMINANTS PART A-CHEMISTRY ANALYSIS CONTROL EXPOSURE & RISK ASSESSMENT (2010)
Percutaneous Ablation of Hepatocellular Carcinoma: Current Status
Justin P. McWilliams et al.
JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY (2010)
Aflatoxin Contamination in Food and Body Fluids in Relation to Malnutrition and Cancer Status in Cameroon
Angele N. Tchana et al.
INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH (2010)
Interactions of chemical carcinogens and genetic variation in hepatocellular carcinoma
Yu-Jing Zhang
WORLD JOURNAL OF HEPATOLOGY (2010)
A model of interaction: Aflatoxins and hepatitis viruses in liver cancer aetiology and prevention
Christopher P. Wild et al.
CANCER LETTERS (2009)
The aflatoxin-induced TP53 mutation at codon 249 (R249S): Biomarker of exposure, early detection and target for therapy
Doriane Gouas et al.
CANCER LETTERS (2009)
Optimizing the yield and utility of circulating cell-free DNA from plasma and serum
Xiaoyan Xue et al.
CLINICA CHIMICA ACTA (2009)
Chromosome instability in human hepatocellular carcinoma depends on p53 status and aflatoxin exposure
Pascal Pineau et al.
MUTATION RESEARCH-GENETIC TOXICOLOGY AND ENVIRONMENTAL MUTAGENESIS (2008)
Circulating tumour-derived nucleic acids in cancer patients: potential applications as tumour markers
K. C. A. Chan et al.
BRITISH JOURNAL OF CANCER (2007)
Quantitative analysis of plasma TP53 249Ser-mutated DNA by electrospray ionization mass spectrometry
ME Lleonart et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2005)
249ser TP53 mutation in plasma DNA, hepatitis B viral infection, and risk of hepatocellular carcinoma
GD Kirk et al.
ONCOGENE (2005)
249ser p53 mutation in the serum of black southern African patients with hepatocellular carcinoma
GC Kimbi et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2005)
Ser-249 p53 mutations in plasma DNA of patients with hepatocellular carcinoma from the Gambia
GD Kirk et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2000)
Share Paper
